350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Election of Three Class I Directors at Annual Meeting on May 27, 2026
Cytokinetics Enters Underwriting Agreement for $760.2 Million Offering
Reports First Quarter 2026 Financial Results and Provides Business Update
Investor Presentation
Annual Report to Security Holders
Reports Fourth Quarter 2025 Financial Results and Provides Business Update
Other Events
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence